1. A. In this chapter, the following terms have the meanings indicated.

2. B. Terms Defined.

   1. (1) “Attending clinician” means an individual who is:

      1. (a) A health care provider as defined in Health-General Article, §5-601, Annotated Code of Maryland; and

      2. (b) Responsible for the care of newborn infants, and is either:

         1. (i) A certified nurse practitioner licensed by the Maryland Board of Nursing; or
         2. (ii) A certified nurse midwife licensed by the Maryland Board of Nursing.

   2. (2) “Attending physician” means an individual who is:

      1. (a) A health care provider as defined in Health-General Article, §5-601, Annotated Code of Maryland;
      2. (b) Responsible for the care of a newborn infant;
      3. (c) Licensed to practice medicine in Maryland; and
      4. (d) Board-certified by a member board of the American Board of Medical Specialties or an approved specialty board of the American Osteopathic Association in a specialty that includes the care of newborn infants.

   3. (3) “Authorized health care provider” means an individual:

      1. (a) Who has received training in the screening protocol; and
      2. (b) For whom the CCHD screening tests are within his or her professional scope of practice.
   4. (4) “Birth Defects Reporting and Information System” means the mandated reporting, monitoring, and follow-up of infants with birth defects as described in Health General Article, §18-206, Annotated Code of Maryland.

   5. (5) Birthing Facility.

      1. (a) “Birthing facility” means a facility that provides care for women during labor and delivery, and their newborn infants.

      2. (b) “Birthing facility” includes a:

         1. (i) Unit of a hospital that is licensed and accredited to provide birthing services; or
         2. (ii) Freestanding birthing center as defined in COMAR 10.05.02.01B.
   6. (6) “CCHD screening” means pulse oximetry testing.
   7. (7) “Critical congenital heart disease (CCHD)” means a congenital heart defect that places an infant at significant risk of disability or death if not diagnosed soon after birth.
   8. (8) “Department” means the Maryland Department of Health.
   9. (9) “Echocardiogram” means a test that uses ultrasound to provide an image of the heart.

   10. (10) “Newborn infant” means an infant in the first 28 days of life who was born:

       1. (a) In Maryland; or
       2. (b) On federal property within Maryland.
   11. (11) “Newborn Screening Follow-Up Unit” means the unit in the Department that carries out the duties set forth in Regulation .07 of this chapter.
   12. (12) “Web-based system” means the web-based database used by the Department to collect data for newborn infant screening follow-up.

Authority: Health-General Article, §§13-109, 13-111, and 18-107(a), Annotated Code of Maryland

Effective date:

Regulations .01—.08 adopted as an emergency provision effective October 5, 2012 (39:22 Md. R. 1427); emergency status extended to June 1, 2013 (40:6 Md. R. 469); adopted permanently effective April 15, 2013 (40:7 Md. R. 612)